IBEX insider buying and SEC filings, explained
IBEX Ltd · CIK 1720420
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.8M
Planned sales (10b5-1)
$2.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 25, 2026 | Planned (10b5-1) | Robert Thomas Dechant (CEO and Director) sold 5,000 shares at about $45.02 ($225K), marked as a 10b5-1 plan trade. Holdings down 2% to 257,011 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 16, 2026 | Sale | Paul Joseph Inson (Chief People Officer) sold 2,500 shares at about $40.07 ($100K). Holdings down 8% to 27,224 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 15, 2026 | Sale | Mingzhe Zhuang (Director) sold 5,522 shares at about $40.10 ($221K). Holdings down 66% to 2,813 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 15, 2026 | Sale | Julie K Casteel (Chief Sales/Marketing Officer) sold 17,474 shares at about $40.41 ($706K). Holdings down 15% to 100,814 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 15, 2026 | Sale | Daniella Ballou-Aares (Director) sold 1,500 shares at $40.29 ($60K). Holdings down 13% to 10,395 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 15–16, 2026 | Sale | Christina Alice Trofimuk-O'Connor (Chief Legal Officer) sold 9,876 shares between Sep 15 and Sep 16 at about $40.07 ($396K). Holdings down 27% to 26,855 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 15, 2026 | Sale | Robert Thomas Dechant (CEO and Director) sold 25,000 shares at about $39.99 ($1.0M). Holdings down 9% to 262,011 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 14, 2026 | Planned (10b5-1) | Paul Joseph Inson (Chief People Officer) sold 2,274 shares at $40.00 ($91K), marked as a 10b5-1 plan trade. Holdings down 7% to 29,724 shares. | SEC filing Filed Sep 15, 2026 |
| Sep 14, 2026 | Planned (10b5-1) | David Martin Afdahl (President / COO) sold 10,819 shares at about $40.07 ($434K), marked as a 10b5-1 plan trade. Holdings down 8% to 129,187 shares. | SEC filing Filed Sep 15, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | David Martin Afdahl (President / COO) sold 17,500 shares at about $37.09 ($649K), marked as a 10b5-1 plan trade. Holdings down 11% to 140,006 shares. | SEC filing Filed Sep 10, 2026 |
| Jun 11, 2026 | Sale | Julie K Casteel (Chief Sales/Marketing Officer) sold 3,600 shares at about $30.61 ($110K). Holdings down 3% to 117,594 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 16, 2026 |
| May 28, 2026 | Sale | Patrick McGinnis (Director) sold 1,030 shares at $31.69 ($33K). Holdings down 15% to 5,833 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 29, 2026 |
| May 22, 2026 | Sale | Taylor C Greenwald (CFO) sold 964 shares at $32.02 ($31K). Holdings down 2% to 62,230 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 13, 2026 | Sale | Robert Thomas Dechant (CEO and Director) sold 7,800 shares at about $30.50 ($238K). Holdings down 3% to 285,606 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 13, 2026 |
| May 11–12, 2026 | Sale | Bruce Neil Dawson (Chief Sales and CS Officer) sold 18,389 shares between May 11 and May 12 at about $31.41 ($578K). Holdings down 23% to 61,895 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 13, 2026 |
| Mar 13–Dec 2, 2025 | Sale | Daniella Ballou-Aares (Director) sold 6,500 shares between Mar 13, 2025 and Dec 2, 2025 at about $25.05 ($163K). Holdings down 38% to 10,643 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 17, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Robert Thomas Dechant (CEO and Director) sold 6,000 shares at about $28.46 ($171K), marked as a 10b5-1 plan trade. Holdings down 2% to 275,406 shares. | SEC filing Filed Feb 23, 2026 |
| Feb 19–20, 2026 | Planned (10b5-1) | Robert Thomas Dechant (CEO and Director) sold 12,000 shares between Feb 19 and Feb 20 at about $29.57 ($355K), marked as a 10b5-1 plan trade. Holdings down 4% to 281,406 shares. | SEC filing Filed Feb 20, 2026 |
| Feb 17–18, 2026 | Planned (10b5-1) | Robert Thomas Dechant (CEO and Director) sold 12,000 shares between Feb 17 and Feb 18 at about $29.81 ($358K), marked as a 10b5-1 plan trade. Holdings down 4% to 293,406 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 6, 2026 | Sale | Michael Joseph Darwal (Chief AI & Digital Officer) sold 1,660 shares at $34.98 ($58K). Holdings down 4% to 42,185 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 12, 2026 |
| Feb 6, 2026 | Sale | Paul Joseph Inson (Chief People Officer) sold 2,627 shares at $34.98 ($92K). Holdings down 9% to 27,469 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
61 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IBEX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.